Literature DB >> 15749872

Small rho GTPases regulate antigen presentation in dendritic cells.

Galina V Shurin1, Irina L Tourkova, Gurkamal S Chatta, Gudula Schmidt, Sheng Wei, Julie Y Djeu, Michael R Shurin.   

Abstract

Dendritic cells (DC) are involved in the regulation of innate and adaptive immunity. However, the molecular mechanisms maintaining DC function remain to be elucidated. In this study, we report on the role of small Rho GTPases: Cdc42, Rac1, and RhoA in the regulation of DC adherence, Ag presentation, migration, chemotaxis, and endocytosis. Murine DC were transfected with vaccinia virus-based constructs, encoding dominant-negative or constitutively active (ca) mutant forms of Rho GTPases. We demonstrate that Cdc42 plays a major role in the regulation of DC adhesion, because caCdc42-transfected DC had significant up-regulation of adhesion to extracellular matrix, which was blocked by the Rho GTPase inhibitor toxin B (ToxB). In contrast, caRho-transfected DC only modestly elevated DC adhesion, and caRac had no effect. Additionally, caCdc42 and caRho increased the ability of DC to present OVA peptide to specific T cells. This effect was abrogated by ToxB. Activation of Cdc42 in DC significantly inhibited spontaneous and chemokine-induced DC migration. Furthermore, uptake of dextran 40 by DC was significantly enhanced by Rho GTPase activators cytotoxic necrotizing factor 1 and PMA, and reduced by ToxB. caCdc42 also increased endocytotic activity of DC, whereas dominant-negative Cdc42 blocked it. Thus, Rho GTPases Cdc42, RhoA, and Rac1 regulate DC functions that are critical for DC-mediated immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749872     DOI: 10.4049/jimmunol.174.6.3394

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis.

Authors:  Mary Canavan; Alice M Walsh; Vipul Bhargava; Sarah M Wade; Trudy McGarry; Viviana Marzaioli; Barry Moran; Monika Biniecka; Hannah Convery; Siobhan Wade; Carl Orr; Ronan Mullan; Jean M Fletcher; Sunil Nagpal; Douglas J Veale; Ursula Fearon
Journal:  JCI Insight       Date:  2018-12-06

2.  DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses.

Authors:  Yosuke Harada; Yoshihiko Tanaka; Masao Terasawa; Markus Pieczyk; Katsuyoshi Habiro; Tomoya Katakai; Kyoko Hanawa-Suetsugu; Mutsuko Kukimoto-Niino; Tomoko Nishizaki; Mikako Shirouzu; Xuefeng Duan; Takehito Uruno; Akihiko Nishikimi; Fumiyuki Sanematsu; Shigeyuki Yokoyama; Jens V Stein; Tatsuo Kinashi; Yoshinori Fukui
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

3.  Primary CD8+ T-cell response to soluble ovalbumin is improved by chloroquine treatment in vivo.

Authors:  Bruno Garulli; Maria G Stillitano; Vincenzo Barnaba; Maria R Castrucci
Journal:  Clin Vaccine Immunol       Date:  2008-08-27

4.  Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells.

Authors:  Galina V Shurin; Irina L Tourkova; Michael R Shurin
Journal:  J Immunother       Date:  2008-06       Impact factor: 4.456

5.  Efficient dendritic cell priming of T lymphocytes depends on the extracellular matrix protein mindin.

Authors:  Hong Li; Tim Oliver; Wei Jia; You-Wen He
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

6.  Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.

Authors:  Hua Zhong; Dmitriy W Gutkin; Baohui Han; Yang Ma; Anton A Keskinov; Michael R Shurin; Galina V Shurin
Journal:  Int J Cancer       Date:  2014-01-20       Impact factor: 7.396

7.  The effect of cyclic mechanical strain on activation of dendritic cells cultured on adhesive substrates.

Authors:  Jamal S Lewis; Natalia V Dolgova; Thomas J Chancellor; Abhinav P Acharya; Jerome V Karpiak; Tanmay P Lele; Benjamin G Keselowsky
Journal:  Biomaterials       Date:  2013-09-03       Impact factor: 12.479

8.  Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer.

Authors:  Michael R Shurin; Alla I Potapovich; Yulia Y Tyurina; Irina L Tourkova; Galina V Shurin; Valerian E Kagan
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

9.  Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells.

Authors:  Alexey V Tkach; Naveena Yanamala; Shyla Stanley; Michael R Shurin; Galina V Shurin; Elena R Kisin; Ashley R Murray; Samantha Pareso; Timur Khaliullin; Gregg P Kotchey; Vincent Castranova; Sanjay Mathur; Bengt Fadeel; Alexander Star; Valerian E Kagan; Anna A Shvedova
Journal:  Small       Date:  2012-08-13       Impact factor: 13.281

10.  Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.

Authors:  Kanneboyina Nagaraju; Rashmi Rawat; Edina Veszelovszky; Rachana Thapliyal; Akanchha Kesari; Susan Sparks; Nina Raben; Paul Plotz; Eric P Hoffman
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.